Viktor Rotbain Curovic

794 total citations
35 papers, 364 citations indexed

About

Viktor Rotbain Curovic is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Viktor Rotbain Curovic has authored 35 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Viktor Rotbain Curovic's work include Diabetes Treatment and Management (21 papers), Diabetes Management and Research (11 papers) and Chronic Kidney Disease and Diabetes (8 papers). Viktor Rotbain Curovic is often cited by papers focused on Diabetes Treatment and Management (21 papers), Diabetes Management and Research (11 papers) and Chronic Kidney Disease and Diabetes (8 papers). Viktor Rotbain Curovic collaborates with scholars based in Denmark, United Kingdom and Germany. Viktor Rotbain Curovic's co-authors include Peter Rossing, Tine W. Hansen, Bernt Johan von Scholten, Emilie H. Zobel, R Ripa, Andreas Kjær, Frederik Persson, Cristina Legido‐Quigley, Tommi Suvitaival and Jacob K. Jensen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Viktor Rotbain Curovic

32 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Rotbain Curovic Denmark 11 168 112 68 66 52 35 364
Mikihiro Nakayama Japan 10 169 1.0× 113 1.0× 112 1.6× 44 0.7× 35 0.7× 16 418
Rosa Montero United Kingdom 10 79 0.5× 61 0.5× 39 0.6× 52 0.8× 28 0.5× 20 299
Domenico Cerullo Italy 10 139 0.8× 152 1.4× 50 0.7× 111 1.7× 44 0.8× 25 428
Qianhua Fang China 9 166 1.0× 120 1.1× 120 1.8× 65 1.0× 114 2.2× 17 388
Raphaela P. Kerindongo Netherlands 11 171 1.0× 126 1.1× 92 1.4× 139 2.1× 22 0.4× 14 429
Akio Ohta Japan 9 188 1.1× 65 0.6× 29 0.4× 90 1.4× 50 1.0× 20 366
Xiaojing Ma China 9 103 0.6× 160 1.4× 42 0.6× 78 1.2× 52 1.0× 13 393
Can Pang China 9 97 0.6× 71 0.6× 70 1.0× 67 1.0× 135 2.6× 14 414
Min Ho Cho South Korea 10 124 0.7× 69 0.6× 82 1.2× 67 1.0× 85 1.6× 25 355
Ines Cilenšek Slovenia 10 67 0.4× 150 1.3× 39 0.6× 20 0.3× 26 0.5× 28 354

Countries citing papers authored by Viktor Rotbain Curovic

Since Specialization
Citations

This map shows the geographic impact of Viktor Rotbain Curovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Rotbain Curovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Rotbain Curovic more than expected).

Fields of papers citing papers by Viktor Rotbain Curovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Rotbain Curovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Rotbain Curovic. The network helps show where Viktor Rotbain Curovic may publish in the future.

Co-authorship network of co-authors of Viktor Rotbain Curovic

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Rotbain Curovic. A scholar is included among the top collaborators of Viktor Rotbain Curovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Rotbain Curovic. Viktor Rotbain Curovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curovic, Viktor Rotbain, et al.. (2025). Combining SGLT2is, GLP1-RAs and nsMRAs in Diabetes: A Scoping Review of Current and Future Perspectives. Diabetes Therapy. 16(5). 799–811. 1 indexed citations
2.
Curovic, Viktor Rotbain, et al.. (2024). Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors. Diabetes Obesity and Metabolism. 26(S6). 22–32. 2 indexed citations
3.
Curovic, Viktor Rotbain, Anne B. Walls, Mie K. Eickhoff, et al.. (2024). Effect of Dapagliflozin on Measured vs. Panel‐Estimated Glomerular Filtration Rate. Clinical Pharmacology & Therapeutics. 117(2). 515–522. 1 indexed citations
4.
5.
Curovic, Viktor Rotbain, Tine W. Hansen, Karolina Sulek, et al.. (2024). Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes. BMJ Open Diabetes Research & Care. 12(2). e003973–e003973. 4 indexed citations
6.
Curovic, Viktor Rotbain, Nete Tofte, Marie Frimodt‐Møller, et al.. (2024). Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease. Journal of Diabetes and its Complications. 38(11). 108879–108879. 2 indexed citations
7.
Ahluwalia, Tarunveer S., Mie K. Eickhoff, Viktor Rotbain Curovic, et al.. (2023). Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease. Kidney International Reports. 9(2). 334–346. 5 indexed citations
8.
Curovic, Viktor Rotbain, Morten Baltzer Houlind, Niels Jongs, et al.. (2023). Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes. Diabetes Obesity and Metabolism. 25(11). 3152–3160. 1 indexed citations
9.
Wretlind, Asger, Viktor Rotbain Curovic, Tommi Suvitaival, et al.. (2023). Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes. Diabetes. 72(10). 1493–1501. 13 indexed citations
10.
Persson, Frederik, et al.. (2023). Renal Effects of Empagliflozin Alone or in Combination with Semaglutide in Albuminuric Type 2 Diabetes: A Randomized, Placebo-Controlled Trial. Journal of the American Society of Nephrology. 34(11S). 16–16. 1 indexed citations
11.
Suvitaival, Tommi, Viktor Rotbain Curovic, Nete Tofte, et al.. (2022). Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes. Cardiovascular Diabetology. 21(1). 135–135. 15 indexed citations
12.
Curovic, Viktor Rotbain, Morten Baltzer Houlind, Tine W. Hansen, et al.. (2022). Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor. Frontiers in Pharmacology. 13. 799915–799915. 3 indexed citations
13.
Curovic, Viktor Rotbain, Mie K. Eickhoff, Marie Frimodt‐Møller, et al.. (2022). Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial. Diabetes Care. 45(11). 2662–2668. 10 indexed citations
14.
Wretlind, Asger, Emilie H. Zobel, Andressa de Zawadzki, et al.. (2022). Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial. SHILAP Revista de lepidopterología. 3. 856485–856485. 2 indexed citations
15.
Ripa, R, Emilie H. Zobel, Bernt Johan von Scholten, et al.. (2021). Effect of Liraglutide on Arterial Inflammation Assessed as [ 18 F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. Circulation Cardiovascular Imaging. 14(7). e012174–e012174. 33 indexed citations
16.
Zobel, Emilie H., R Ripa, Bernt Johan von Scholten, et al.. (2021). Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo‐controlled trial. Diabetes Obesity and Metabolism. 23(12). 2651–2659. 10 indexed citations
17.
Zobel, Emilie H., R Ripa, Bernt Johan von Scholten, et al.. (2021). Effect of liraglutide on expression of inflammatory genes in type 2 diabetes. Scientific Reports. 11(1). 18522–18522. 44 indexed citations
18.
Zobel, Emilie H., R Ripa, Bernt Johan von Scholten, et al.. (2021). Effect of Liraglutide on Vascular Inflammation Evaluated by [64Cu]DOTATATE. Diagnostics. 11(8). 1431–1431. 8 indexed citations
19.
Jensen, Jacob K., Emilie H. Zobel, Bernt Johan von Scholten, et al.. (2021). Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers in Endocrinology. 12. 790405–790405. 28 indexed citations
20.
Curovic, Viktor Rotbain, Simone Theilade, Signe Abitz Winther, et al.. (2020). Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes. Diabetic Medicine. 38(5). e14459–e14459. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikihiro Nakayama Breakdown of academic impact, for papers by Rosa Montero Breakdown of academic impact, for papers by Domenico Cerullo Breakdown of academic impact, for papers by Qianhua Fang Breakdown of academic impact, for papers by Raphaela P. Kerindongo Breakdown of academic impact, for papers by Akio Ohta Breakdown of academic impact, for papers by Xiaojing Ma Breakdown of academic impact, for papers by Can Pang Breakdown of academic impact, for papers by Min Ho Cho Breakdown of academic impact, for papers by Ines Cilenšek
Rankless by CCL
2026